Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 09/12/2025 | CALL | $26.00 | 11,365 | +10,513 | +1,233.92% |
| 09/12/2025 | CALL | $24.50 | 10,427 | +10,427 | |
| 09/12/2025 | CALL | $27.00 | 25,543 | +9,983 | +64.16% |
| 09/12/2025 | CALL | $25.00 | 10,606 | +9,808 | +1,229.07% |
| 11/21/2025 | PUT | $23.00 | 1,881 | +1,571 | +506.77% |
| 09/19/2025 | PUT | $20.00 | 6,284 | +1,286 | +25.73% |
| 09/05/2025 | PUT | $24.00 | 2,498 | -888 | -26.23% |
| 09/19/2025 | PUT | $28.00 | 2,696 | -905 | -25.13% |
| 09/05/2025 | CALL | $27.50 | 13,589 | -1,500 | -9.94% |
| 09/05/2025 | PUT | $27.50 | 463 | -1,876 | -80.21% |
| 09/05/2025 | CALL | $27.00 | 6,487 | -7,870 | -54.82% |
| 09/05/2025 | CALL | $25.50 | 9,211 | -11,149 | -54.76% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.57% | 9.93M | 1.25B |
| Vanguard International Growth Fund | 2.53% | 9.77M | 1.23B |
| Vanguard 500 Index Fund | 1.98% | 7.64M | 961.76M |
| Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 1.31% | 5.08M | 639.64M |
| Fidelity 500 Index Fund | 0.94% | 3.62M | 456.08M |
| SPDR S&P 500 ETF Trust | 0.92% | 3.57M | 449.61M |
| Vanguard Specialized-Health Care Fund | 0.90% | 3.49M | 439.87M |
| Growth Fund Of America Inc | 0.80% | 3.11M | 391.58M |
| iShares Core S&P 500 ETF | 0.76% | 2.95M | 371.32M |
| Vanguard U.S. Growth Fund | 0.75% | 2.88M | 362.55M |
Untreated Metastatic or Unresectable Melanoma Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight
08/26 01:00 pm
GlobeNewswire Inc.
Read moreUnderstanding the Nanomedicine Landscape: Key Players and Emerging Trends
08/21 04:38 am
GlobeNewswire Inc.
Read moreIf You're in Your 30s, Consider Buying These 2 Healthcare Stocks
08/17 09:30 am
The Motley Fool
Read moreCDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency
08/12 01:41 pm
Benzinga
Read moreGlobal Cancer Vaccines Market to Surpass USD 15.00 Billion by 2032, Unlocking Over USD 10 Billion in New Growth Opportunities | MarketsandMarkets™.
08/11 09:00 am
GlobeNewswire Inc.
Read moreCytomX (CTMX) Q2 Revenue Drops 26%
08/07 06:29 pm
The Motley Fool
Read moreLipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034
08/05 06:00 am
GlobeNewswire Inc.
Read moreModerna's Key Patent Win Overshadowed By Gloomy Outlook
08/01 08:44 am
Benzinga
Read moreAlnylam Pharmaceuticals Q2 Earnings Crush Estimates, Stock Hits 52-Week High On Upbeat Forecast
07/31 03:36 pm
Benzinga
Read moreOpinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash
07/14 08:30 pm
The Motley Fool
Read moreDelta Air, Moderna And Coinbase Are Among Top Large Cap Gainers Last Week (July 7-July 11): Are The Others In Your Portfolio?
07/13 11:02 am
Benzinga
Read moreWhere Will Moderna Be in 10 Years?
07/05 05:10 am
The Motley Fool
Read moreModerna's mRNA Flu Vaccine Outperforms Standard Shots
06/30 09:51 am
Benzinga
Read moreFlu RNA Vaccines Market Research Report 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges
06/20 10:59 am
GlobeNewswire Inc.
Read moreModerna Beats Alnylam Appeal In COVID Vaccine Patent Case
06/05 11:59 am
Benzinga
Read moreModerna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals
06/02 08:35 am
Benzinga
Read moreRobert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children
05/27 12:29 pm
Benzinga
Read moreMRK Down 21% YTD: Should You Buy, Hold or Sell the Stock?
05/26 11:01 am
Zacks Investment Research
Read moreModerna Stock Looks Ripe for a Short Squeeze
05/22 08:21 am
Investing.com
Read more1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid
05/16 05:30 am
The Motley Fool
Read moreModerna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026
05/01 01:14 pm
Benzinga
Read moreCytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting
04/28 04:00 pm
GlobeNewswire Inc.
Read moreMarket Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and Hold
04/26 09:30 am
The Motley Fool
Read moreUS Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
04/17 03:31 pm
Benzinga
Read moreStocks Edge Up On Strong Bank Earnings, Netflix Soars, Dollar Rebounds: What's Driving Markets Tuesday?
04/15 01:27 pm
Benzinga
Read moreStocks Notch Best Week In Years As Dip Buying On Tariff Crisis Gathers Momentum
04/11 04:36 pm
Benzinga
Read moreBetter Beaten-Down Stock to Buy: Pfizer Vs. Moderna
04/03 08:30 am
The Motley Fool
Read moreWhy Moderna Stock Is Plummeting Today
03/31 01:58 pm
The Motley Fool
Read moreBuying These Dirt-Cheap Stocks Could Be a Brilliant Move
03/22 06:44 am
The Motley Fool
Read more4 Things You Need to Know if You Buy Moderna Stock Today
03/20 08:45 am
The Motley Fool
Read more2 No-Brainer Biotech Stocks to Buy Right Now
03/19 06:10 pm
The Motley Fool
Read moreDown 93%, Is It Finally Time to Buy Moderna?
03/15 04:38 am
The Motley Fool
Read moreWhere Will Vertex Pharmaceuticals Be in 10 Years?
03/11 04:25 am
The Motley Fool
Read moreBioNTech Surpasses Q4 Revenue Estimates
03/10 08:42 am
The Motley Fool
Read more3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
02/28 04:15 am
The Motley Fool
Read moreCan Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?
02/27 11:05 am
The Motley Fool
Read moreGlobal Vaccine Contract Manufacturing Market to Boost with a Significant ~7% CAGR by 2032 | DelveInsight
02/24 02:00 pm
GlobeNewswire Inc.
Read moreWill Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.
02/20 04:22 am
The Motley Fool
Read moreModerna's Q4 Loss Wider Than Expected
02/14 12:33 pm
The Motley Fool
Read moreModerna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides
02/14 09:04 am
Benzinga
Read moreRespiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider
02/13 10:00 am
GlobeNewswire Inc.
Read moreDeadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch
02/10 12:15 pm
Benzinga
Read more2 Biotech Stocks to Buy Hand Over Fist in February
02/09 12:15 pm
The Motley Fool
Read more3 Top AI-Powered Biotech Stocks to Buy in February
02/06 10:45 am
The Motley Fool
Read moreUp More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock?
01/30 10:15 am
The Motley Fool
Read morePotential Revolution in Healthcare Brewing, Powered by AI Innovation
01/29 09:04 am
Benzinga
Read moreNetflix, Palantir And Moderna Are Among Top 12 Large Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio?
01/26 09:30 am
Benzinga
Read more